The Mia40 substrate Mix17 exposes its N-terminus to the cytosolic side of the mitochondrial outer membrane

Area of Science:

• Mitochondrial biology
• Protein biogenesis
• Neurodegenerative disease research

Background:

• Mitochondrial architecture relies on the MICOS complex, crucial for inner and outer membrane contact.
• Mutations in MICOS subunit Mic14 (CHCHD10) are associated with amyotrophic lateral sclerosis and frontotemporal dementia.
• The function of Mix17, a yeast ortholog of Mic14, remains largely unknown, with no prior evidence of MICOS interaction.

Purpose of the Study:

• To elucidate the function of the yeast protein Mix17 and its orthologs.
• To investigate Mix17's interactions, biogenesis, and mitochondrial localization.
• To understand Mix17's role in mitochondrial outer membrane protein import.

Main Methods:

• Analysis of protein interactions.
• Investigation of protein biogenesis pathways.
• Mitochondrial sublocalization studies.
• Biochemical assays to identify protein substrates and import mechanisms.

Main Results:

• Mix17 is not a stable component of the yeast MICOS complex.
• Mix17 is identified as a novel substrate for Mia40, localized to the mitochondrial outer membrane.
• Mix17 uniquely spans the mitochondrial outer membrane with its N-terminus exposed to the cytosol.
• Tom40, the TOM complex pore, is implicated in Mix17's mitochondrial outer membrane insertion.
• The N-terminus of Mix17 is essential for its cytosolic exposure.

Conclusions:

• Mix17's function is distinct from stable MICOS subunits.
• Mix17 represents the first identified Mia40 substrate in the mitochondrial outer membrane.
• The unique topology and insertion mechanism of Mix17 provide insights into mitochondrial protein sorting and import.
• Understanding Mix17's biogenesis may offer new perspectives on neurodegenerative diseases linked to MICOS dysfunction.